Dexcom Stock Jumps As Q2 Earnings Beats Street, Raises Guidance; Analysts Bump Up Target Price
See more from Benzinga
Abbott Launches Latest Insertable Cardiac Monitor For Irregular Heart Rhythms
Veracyte Stock Moves Higher As Q2 Earnings Surpass Expectations; Analysts Raise Price Target
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.